|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Investments | ||||||||||||||||
| Control Investments | ||||||||||||||||
| Affiliate Investments | ||||||||||||||||
| Non-Control / Non-Affiliate Investments | ||||||||||||||||
| Total investments | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Deferred credit facility costs | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Credit facility | ||||||||||||||||
| Secured Notes, net of $1,249 and $1,467, respectively, of unamortized deferred financing costs | ||||||||||||||||
| Notes | ||||||||||||||||
| 2025 Notes | ||||||||||||||||
| Series A Notes | ||||||||||||||||
| August 2026 Notes | ||||||||||||||||
| March 2029 Notes | ||||||||||||||||
| September 2029 Notes | ||||||||||||||||
| December 2026 Notes | ||||||||||||||||
| Convertible Notes, net of $605 and $1,243, respectively, of unamortized deferred financing costs and discount | ||||||||||||||||
| Unsecured Notes, net of $14,469 and $10,118, respectively, of unamortized deferred financing costs and premium/discount | ||||||||||||||||
| Distribution payable | ||||||||||||||||
| Security deposits | ||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| Common stock, $0.001 par value per share (200,000,000 authorized, 94,023,371 and 81,518,294 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||
| Paid-in capital in excess of par | ||||||||||||||||
| Distributable earnings/(accumulated deficit) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| NET ASSET VALUE PER SHARE | ||||||||||||||||
Loading...